A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...
Fintel reports that on March 5, 2025, Canaccord Genuity initiated coverage of Marker Therapeutics (NasdaqCM:MRKR) with a Buy recommendation. Analyst Price Forecast Suggests 750.00% Upside As of March ...
Marker has advanced its manufacturing technology, reducing overall manufacturing time to nine days and generating a product with higher potency due to improved T cell composition and specificity.
An AI-based computer model makes aging visible at the cellular level for the first time. Researchers have applied it to ...
Dr. Yang Jian, leader of the team that published the Nature article unveiling a new method known simply as "gsMap" Photo: ...
will present at the H.C. Wainwright 3 rd Annual Cell Therapy Virtual Conference. This virtual investor event will be held on February 25, 2025. Dr. Vera will present an overview of Marker’s technology ...
They may also be a useful diagnostic marker when creating treatment plans. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.